Respiratory syncytial virus immunoprophylaxis in high-risk infants and development of childhood asthma

详细信息    查看全文

• 作者：Kecia N. Carroll ; MD ; MPH^a ; ^e ; Tebeb Gebretsadik ; MPH^b ; ^e ; Gabriel J. Escobar ; MD^f ; ^g ; ^h ; Pingsheng Wu ; PhD^b ; ^c ; ^e ; Sherian Xu Li ; MS^g ; Eileen M. Walsh ; RN^g ; Ed Mitchel ; MS^d ; ^e ; Chantel D. Sloan ; PhD^e ; ⁱ ; William D. Dupont ; PhD^b ; ^e ; Tina V. Hartert ; MD ; MPH^c ; ^e ; ^{tina.hartert@vanderbilt.edu}
• 关键词：Respiratory syncytial virus ; lower respiratory tract infection ; bronchiolitis ; respiratory syncytial virus immunoprophylaxis ; palivizumab ; wheezing ; asthma ; primary prevention
• 刊名：Journal of Allergy and Clinical Immunology
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：139
• 期：1
• 页码：66-71.e3
• 全文大小：524 K
• 卷排序：139

文摘

Respiratory syncytial virus (RSV) lower respiratory tract infection is implicated in asthma development. RSV immunoprophylaxis during infancy is efficacious in preventing RSV-related hospitalizations and has been associated with decreased wheezing in the first years of life.ObjectiveWe investigated whether greater adherence to immunoprophylaxis in infants at high risk for severe RSV would be associated with decreased childhood asthma.MethodsWe conducted a retrospective cohort investigation including children born from 1996-2003 who were enrolled in Kaiser Permanente Northern California or Tennessee Medicaid and eligible to receive RSV immunoprophylaxis. Asthma was defined at 4.5 to 6 years of age by using asthma-specific health care visits and medication fills. We classified children into immunoprophylaxis eligibility groups and calculated adherence (percentage receipt of recommended doses). We used a set of statistical strategies (multivariable logistic regression and propensity score [PS]–adjusted and PS-matched analyses) to overcome confounding by medical complexity because infants with higher adherence (≥70%) have higher prevalence of chronic lung disease, lower birth weight, and longer nursery stays.ResultsBy using multivariable logistic regression and PS-adjusted models in the combined group, higher adherence to RSV immunoprophylaxis was not associated with decreased asthma. However, in PS-matched analysis, treated children with 70% or greater adherence had decreased odds of asthma compared with those with 20% or less adherence (odds ratio, 0.62; 95% CI, 0.50-0.78).ConclusionsThis investigation of RSV immunoprophylaxis in high-risk children primarily found nonsignificant associations on prevention of asthma in specific preterm groups. Our findings highlight the need for larger studies and prospective cohorts and provide estimates of potential preventive effect sizes in high-risk children.